BioMed Research International

BioMed Research International / 2003 / Article
Special Issue

Gene Therapy — Part II

View this Special Issue

Review article | Open Access

Volume 2003 |Article ID 740305 | https://doi.org/10.1155/S1110724303209074

Tracy Robson, David G. Hirst, "Transcriptional Targeting in Cancer Gene Therapy", BioMed Research International, vol. 2003, Article ID 740305, 28 pages, 2003. https://doi.org/10.1155/S1110724303209074

Transcriptional Targeting in Cancer Gene Therapy

Received10 Jun 2002
Accepted19 Jul 2002

Abstract

Cancer gene therapy has been one of the most exciting areas of therapeutic research in the past decade. In this review, we discuss strategies to restrict transcription of transgenes to tumour cells. A range of promoters which are tissue-specific, tumour-specific, or inducible by exogenous agents are presented. Transcriptional targeting should prevent normal tissue toxicities associated with other cancer treatments, such as radiation and chemotherapy. In addition, the specificity of these strategies should provide improved targeting of metastatic tumours following systemic gene delivery. Rapid progress in the ability to specifically control transgenes will allow systemic gene delivery for cancer therapy to become a real possibility in the near future.

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views193
Downloads750
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.